Meeting
2020 ASCO Virtual Scientific Program
Acquired RB1 mutations in estrogen receptor-positive (ER+) clinically advanced and metastatic breast cancer (MBC).
Authors
Kimberly McGregor
Foundation Medicine, Cambridge, MA
Kimberly McGregor , Ethan Sokol , Natalie Danziger , Dean Pavlick , Julia Andrea Elvin , Jo-Anne Vergilio , Jonathan Keith Killian , Douglas I. Lin , Erik Abraham Williams , Shakti H. Ramkissoon , Eric Allan Severson , Amanda Hemmerich , Daniel Duncan , Richard Huang , Jon Chung , Venkataprasanth P. Reddy , Jeffrey Venstrom , Alexa Betzig Schrock , Brian Michael Alexander , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Hormone Receptor-Positive
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1053)
DOI
10.1200/JCO.2020.38.15_suppl.1053
Abstract #
1053
Poster Bd #
138
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of clinically advanced and metastatic cutaneous adnexal carcinomas (CAs; MCADCA): A genomic landscape study.
First Author: Maroun Bou Zerdan
Poster
2023 ASCO Annual Meeting
CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).
First Author: Kyle M Rose
First Author: Neal A. Fischbach
Poster
2022 ASCO Annual Meeting
Targetable genomic mutations in young women with advanced breast cancer.
First Author: Norin Ansari